177 related articles for article (PubMed ID: 18387304)
1. Structure-based discovery of a novel non-peptidic small molecular inhibitor of caspase-3.
Sakai J; Yoshimori A; Nose Y; Mizoroki A; Okita N; Takasawa R; Tanuma S
Bioorg Med Chem; 2008 May; 16(9):4854-9. PubMed ID: 18387304
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
Yoshimori A; Sakai J; Sunaga S; Kobayashi T; Takahashi S; Okita N; Takasawa R; Tanuma S
BMC Pharmacol; 2007 Jun; 7():8. PubMed ID: 17594508
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach.
Lakshmi PJ; Kumar BV; Nayana RS; Mohan MS; Bolligarla R; Das SK; Bhanu MU; Kondapi AK; Ravikumar M
Bioorg Med Chem; 2009 Aug; 17(16):6040-7. PubMed ID: 19631549
[TBL] [Abstract][Full Text] [Related]
4. Solid-phase synthesis of azidomethylene inhibitors targeting cysteine proteases.
Yang PY; Wu H; Lee MY; Xu A; Srinivasan R; Yao SQ
Org Lett; 2008 May; 10(10):1881-4. PubMed ID: 18407644
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel class of reversible non-peptide caspase inhibitors via a structure-based approach.
Fattorusso R; Jung D; Crowell KJ; Forino M; Pellecchia M
J Med Chem; 2005 Mar; 48(5):1649-56. PubMed ID: 15743206
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
7. Structure of human caspase-6 in complex with Z-VAD-FMK: New peptide binding mode observed for the non-canonical caspase conformation.
Müller I; Lamers MB; Ritchie AJ; Dominguez C; Munoz-Sanjuan I; Kiselyov A
Bioorg Med Chem Lett; 2011 Sep; 21(18):5244-7. PubMed ID: 21820899
[TBL] [Abstract][Full Text] [Related]
8. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
[TBL] [Abstract][Full Text] [Related]
9. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
Yoshimori A; Takasawa R; Tanuma S
BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
[TBL] [Abstract][Full Text] [Related]
10. Exploiting differences in caspase-2 and -3 S₂ subsites for selectivity: structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors.
Maillard MC; Brookfield FA; Courtney SM; Eustache FM; Gemkow MJ; Handel RK; Johnson LC; Johnson PD; Kerry MA; Krieger F; Meniconi M; Muñoz-Sanjuán I; Palfrey JJ; Park H; Schaertl S; Taylor MG; Weddell D; Dominguez C
Bioorg Med Chem; 2011 Oct; 19(19):5833-51. PubMed ID: 21903398
[TBL] [Abstract][Full Text] [Related]
11. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
Agniswamy J; Fang B; Weber IT
FEBS J; 2007 Sep; 274(18):4752-65. PubMed ID: 17697120
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
Reszka P; Schulz R; Methling K; Lalk M; Bednarski PJ
ChemMedChem; 2010 Jan; 5(1):103-17. PubMed ID: 19918833
[TBL] [Abstract][Full Text] [Related]
13. Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway.
Glória PM; Coutinho I; Gonçalves LM; Baptista C; Soares J; Newton AS; Moreira R; Saraiva L; Santos MM
Eur J Med Chem; 2011 Jun; 46(6):2141-6. PubMed ID: 21439692
[TBL] [Abstract][Full Text] [Related]
14. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
15. Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach.
Wang JG; Xiao YJ; Li YH; Ma Y; Li ZM
Bioorg Med Chem; 2007 Jan; 15(1):374-80. PubMed ID: 17049866
[TBL] [Abstract][Full Text] [Related]
16. Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach.
Lucas S; Heim R; Negri M; Antes I; Ries C; Schewe KE; Bisi A; Gobbi S; Hartmann RW
J Med Chem; 2008 Oct; 51(19):6138-49. PubMed ID: 18763754
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
Fang B; Fu G; Agniswamy J; Harrison RW; Weber IT
Apoptosis; 2009 May; 14(5):741-52. PubMed ID: 19283487
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.
Aulabaugh A; Kapoor B; Huang X; Dollings P; Hum WT; Banker A; Wood A; Ellestad G
Biochemistry; 2007 Aug; 46(33):9462-71. PubMed ID: 17649976
[TBL] [Abstract][Full Text] [Related]
19. Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
Barrett DG; Catalano JG; Deaton DN; Hassell AM; Long ST; Miller AB; Miller LR; Ray JA; Samano V; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
Bioorg Med Chem Lett; 2006 Mar; 16(6):1735-9. PubMed ID: 16376075
[TBL] [Abstract][Full Text] [Related]
20. Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite.
Vázquez J; García-Jareño A; Mondragón L; Rubio-Martinez J; Pérez-Payá E; Albericio F
ChemMedChem; 2008 Jun; 3(6):979-85. PubMed ID: 18393268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
